229 related articles for article (PubMed ID: 12574424)
1. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.
Xiong ZQ; Qian W; Suzuki K; McNamara JO
J Neurosci; 2003 Feb; 23(3):955-60. PubMed ID: 12574424
[TBL] [Abstract][Full Text] [Related]
2. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
3. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement.
Esser AF; Sodetz JM
Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325
[No Abstract] [Full Text] [Related]
4. Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.
Lovelace LL; Cooper CL; Sodetz JM; Lebioda L
J Biol Chem; 2011 May; 286(20):17585-92. PubMed ID: 21454577
[TBL] [Abstract][Full Text] [Related]
5. Membrane attack by complement.
Podack ER; Tschopp J
Mol Immunol; 1984 Jul; 21(7):589-603. PubMed ID: 6379417
[TBL] [Abstract][Full Text] [Related]
6. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
7. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.
Podack ER; Biesecker G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):897-901. PubMed ID: 284414
[TBL] [Abstract][Full Text] [Related]
8. CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers.
Menny A; Serna M; Boyd CM; Gardner S; Joseph AP; Morgan BP; Topf M; Brooks NJ; Bubeck D
Nat Commun; 2018 Dec; 9(1):5316. PubMed ID: 30552328
[TBL] [Abstract][Full Text] [Related]
9. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel.
Ramm LE; Whitlow MB; Mayer MM
Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4751-5. PubMed ID: 6289316
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
13. Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.
Blom AM; Bergmann S; Fulde M; Riesbeck K; Agarwal V
J Biol Chem; 2014 Nov; 289(47):32499-511. PubMed ID: 25281746
[TBL] [Abstract][Full Text] [Related]
14. Single-molecule kinetics of pore assembly by the membrane attack complex.
Parsons ES; Stanley GJ; Pyne ALB; Hodel AW; Nievergelt AP; Menny A; Yon AR; Rowley A; Richter RP; Fantner GE; Bubeck D; Hoogenboom BW
Nat Commun; 2019 May; 10(1):2066. PubMed ID: 31061395
[TBL] [Abstract][Full Text] [Related]
15. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
16. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
17. Fluid-phase assembly of the membrane attack complex of complement.
Silversmith RE; Nelsestuen GL
Biochemistry; 1986 Feb; 25(4):841-51. PubMed ID: 3964648
[TBL] [Abstract][Full Text] [Related]
18. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
19. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
Zalman LS; Müller-Eberhard H
Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
[TBL] [Abstract][Full Text] [Related]
20. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]